FDA Inspection 1292208 — David S. Krakow, M.D.

David S. Krakow, M.D. — FEI 3039842677

The FDA completed an inspection of David S. Krakow, M.D. on Nov 21, 2025 in Mount Kisco, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 21, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mount Kisco, NY (United States)

Additional details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.